Terumo Blood and Cell Technologies
Manufactures medical devices for blood and cell therapy processing.
Company facts
- Founded
- 1964
- Employees
- 8,000
- Headquarters
- United States
- CEO
- Antoinette Gawin
- Type
- Public
- Listed
- Tokyo Stock Exchange: 4543
About
Terumo BCT is a global leader in blood management, blood safety, therapeutic apheresis, cell therapy, and cell collections. Founded in 1964, Terumo BCT has been dedicated to advancing healthcare by unlocking the potential of blood and cells. The company operates in over 130 countries and is committed to enhancing patient outcomes through innovation and collaboration with healthcare professionals. Terumo BCT offers a broad range of products and services designed to improve blood collection, processing, and transfusion practices. With nearly 7,000 associates worldwide, Terumo BCT aims to exceed customer expectations by providing effective solutions to meet the needs of patients. The company leverages state-of-the-art technology, including the latest advances in apheresis equipment and therapeutic cell processing. Through strategic partnerships and a commitment to quality, Terumo BCT continues to lead in the healthcare sector, dedicated to improving the lives of patients around the globe.